PLN 2.98
(-0.83%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 72.85 Million PLN | -23.91% |
2022 | 95.75 Million PLN | 23.09% |
2021 | 77.78 Million PLN | -25.7% |
2020 | 104.69 Million PLN | 2.48% |
2019 | 102.16 Million PLN | -12.02% |
2018 | 116.12 Million PLN | -37.66% |
2017 | 186.27 Million PLN | 34.96% |
2016 | 138.02 Million PLN | -17.39% |
2015 | 167.08 Million PLN | 5.55% |
2014 | 158.29 Million PLN | 8.57% |
2013 | 145.8 Million PLN | -31.7% |
2012 | 213.46 Million PLN | 108.08% |
2011 | 102.58 Million PLN | -51.73% |
2010 | 212.53 Million PLN | 90.95% |
2009 | 111.3 Million PLN | -13.82% |
2008 | 129.14 Million PLN | -12.74% |
2007 | 148 Million PLN | 10.59% |
2006 | 133.83 Million PLN | 64.85% |
2005 | 81.18 Million PLN | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 17.58 Million PLN | 59.15% |
2024 Q1 | 11.04 Million PLN | -44.38% |
2023 Q3 | 14.48 Million PLN | -23.14% |
2023 Q2 | 18.83 Million PLN | -4.21% |
2023 Q1 | 19.66 Million PLN | -44.81% |
2023 FY | 72.85 Million PLN | -23.91% |
2023 Q4 | 19.86 Million PLN | 37.2% |
2022 Q2 | 23.05 Million PLN | 48.25% |
2022 Q3 | 21.51 Million PLN | -6.65% |
2022 Q4 | 35.63 Million PLN | 65.59% |
2022 FY | 95.75 Million PLN | 23.09% |
2022 Q1 | 15.54 Million PLN | -27.17% |
2021 FY | 77.78 Million PLN | -25.7% |
2021 Q1 | 16.42 Million PLN | -58.51% |
2021 Q4 | 21.35 Million PLN | -7.95% |
2021 Q2 | 16.81 Million PLN | 2.4% |
2021 Q3 | 23.19 Million PLN | 37.92% |
2020 Q4 | 39.58 Million PLN | 81.84% |
2020 FY | 104.69 Million PLN | 2.48% |
2020 Q1 | 14.78 Million PLN | -45.45% |
2020 Q2 | 28.55 Million PLN | 93.08% |
2020 Q3 | 21.76 Million PLN | -23.76% |
2019 Q1 | 5.22 Million PLN | -46.06% |
2019 Q2 | 47.58 Million PLN | 811.18% |
2019 Q3 | 22.25 Million PLN | -53.24% |
2019 Q4 | 27.11 Million PLN | 21.85% |
2019 FY | 102.16 Million PLN | -12.02% |
2018 Q3 | 21.64 Million PLN | -46.54% |
2018 Q1 | 44.31 Million PLN | -30.17% |
2018 FY | 116.12 Million PLN | -37.66% |
2018 Q2 | 40.48 Million PLN | -8.66% |
2018 Q4 | 9.68 Million PLN | -55.26% |
2017 Q4 | 63.47 Million PLN | 40.85% |
2017 FY | 186.27 Million PLN | 34.96% |
2017 Q3 | 45.06 Million PLN | 0.76% |
2017 Q2 | 44.72 Million PLN | 35.46% |
2017 Q1 | 33.01 Million PLN | 63.0% |
2016 Q4 | 20.25 Million PLN | -41.81% |
2016 FY | 138.02 Million PLN | -17.39% |
2016 Q1 | 40.66 Million PLN | -1.51% |
2016 Q2 | 42.29 Million PLN | 4.02% |
2016 Q3 | 34.8 Million PLN | -17.71% |
2015 FY | 167.08 Million PLN | 5.55% |
2015 Q4 | 41.28 Million PLN | -19.73% |
2015 Q3 | 51.43 Million PLN | 24.94% |
2015 Q2 | 41.17 Million PLN | 24.05% |
2015 Q1 | 33.18 Million PLN | -32.7% |
2014 FY | 158.29 Million PLN | 8.57% |
2014 Q3 | 39.2 Million PLN | 1.32% |
2014 Q2 | 38.69 Million PLN | 24.5% |
2014 Q4 | 49.31 Million PLN | 25.78% |
2014 Q1 | 31.08 Million PLN | -23.31% |
2013 FY | 145.8 Million PLN | -31.7% |
2013 Q4 | 40.53 Million PLN | 15.16% |
2013 Q2 | 33.84 Million PLN | -6.6% |
2013 Q1 | 36.23 Million PLN | -7.16% |
2013 Q3 | 35.19 Million PLN | 3.98% |
2012 Q2 | 24.91 Million PLN | -78.39% |
2012 Q1 | 115.29 Million PLN | 267.12% |
2012 FY | 213.46 Million PLN | 108.08% |
2012 Q3 | 34.22 Million PLN | 37.35% |
2012 Q4 | 39.03 Million PLN | 14.06% |
2011 Q3 | 26.11 Million PLN | -0.44% |
2011 FY | 102.58 Million PLN | -51.73% |
2011 Q1 | 18.83 Million PLN | -86.92% |
2011 Q2 | 26.23 Million PLN | 39.26% |
2011 Q4 | 31.4 Million PLN | 20.26% |
2010 Q1 | 16.74 Million PLN | -61.7% |
2010 Q3 | 21.13 Million PLN | -31.04% |
2010 FY | 212.53 Million PLN | 90.95% |
2010 Q4 | 144 Million PLN | 581.3% |
2010 Q2 | 30.64 Million PLN | 83.08% |
2009 Q3 | 19.16 Million PLN | -31.43% |
2009 Q4 | 43.71 Million PLN | 128.05% |
2009 Q2 | 27.95 Million PLN | 36.55% |
2009 Q1 | 20.47 Million PLN | 0.0% |
2009 FY | 111.3 Million PLN | -13.82% |
2008 FY | 129.14 Million PLN | -12.74% |
2007 FY | 148 Million PLN | 10.59% |
2006 FY | 133.83 Million PLN | 64.85% |
2005 FY | 81.18 Million PLN | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Bioceltix S.A. | -1.03 Million PLN | 7118.08% |
Captor Therapeutics Spolka Akcyjna | 6.9 Million PLN | -955.688% |
Mabion S.A. | 114.58 Million PLN | 36.419% |
Molecure S.A. | -4.1 Million PLN | 1876.205% |
NanoGroup S.A. | -79.01 Thousand PLN | 92299.147% |
Pharmena S.A. | 5.84 Million PLN | -1146.842% |
Poltreg S.A. | -1.38 Million PLN | 5352.559% |
Pure Biologics SpĆ³lka Akcyjna | -2.57 Million PLN | 2930.342% |
Ryvu Therapeutics S.A. | 29.3 Million PLN | -148.594% |
Synthaverse S.A. | 35.16 Million PLN | -107.163% |
Urteste S.A. | -479 Thousand PLN | 15309.395% |